search
Back to results

Outcomes for 2 Operations Versus ≥ 3 Operations in Infected Wounds

Primary Purpose

Wound Infection

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Debridement
Sponsored by
Georgetown University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Wound Infection

Eligibility Criteria

18 Years - 90 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Infected wound requiring hospital admission
  • Infected wound requiring an operative intervention
  • Wound can be located anywhere on the body
  • Patient able and willing to comply with all study requirements

Exclusion Criteria:

  • Planned free tissue flap for soft tissue reconstruction
  • Wound located over exposed joint implant
  • Wound located over exposed hardware
  • Disease or treatment causing substantial immunosuppression
  • History of collagen vascular disease
  • Transplant recipient
  • Venous stasis ulcer
  • Radiation-induced ulcer
  • Contraindication for use of negative pressure wound therapy with instillation of normal saline
  • Unable or unwilling to comply with study requirements

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Active Comparator

    Arm Label

    2 operations

    3 or more operations

    Arm Description

    Subjects in this arm will receive a maximum of two surgical debridements of their wound.

    Subjects in this arm will receive three or more surgical debridements of their wound.

    Outcomes

    Primary Outcome Measures

    Number of post-hospital discharge complications between subjects who received 2 versus 3 or more debridement operations prior to closure.

    Secondary Outcome Measures

    Full Information

    First Posted
    September 23, 2015
    Last Updated
    September 10, 2019
    Sponsor
    Georgetown University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02559453
    Brief Title
    Outcomes for 2 Operations Versus ≥ 3 Operations in Infected Wounds
    Official Title
    A Randomized Trial Comparing the Outcomes for 2 Operations Versus ≥ 3 Operations in Infected Wounds Requiring Hospitalization
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    September 2019
    Overall Recruitment Status
    Unknown status
    Study Start Date
    September 2015 (undefined)
    Primary Completion Date
    March 2020 (Anticipated)
    Study Completion Date
    June 2020 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Georgetown University

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    We have designed this study to determine whether performing two, compared with ≥3 operations has an effect on key clinical outcomes after discharge from the hospital of an infected wound that requires admission. Each arm of this study represents the two commonly practiced standard of care treatment plans for patients presenting with infected wounds. It is currently unknown which SoC option provides the best patient outcome.
    Detailed Description
    There is a lack of consensus about whether or not a patient with an infected wound requires more than 2 surgical procedures. For patients admitted for an infected wound this study will investigate whether 2, compared with ≥3, operative interventions results in better outcomes. All patients admitted for an infected wound will be assessed for eligibility in the study. If eligible, subjects will be randomized into Cohort A (2 operative visits) or Cohort B (≥3 operative visits). Subjects will then be followed during the hospitalization as well as 180 days post discharge. A total of 250 subjects will be enrolled into this study. Two operations (n=125) will be compared with ≥3 operations (n=125) during the hospitalization. We will compare the following factors between the two treatment groups: length of hospital stay; readmission post-discharge; quality of life; proportion of wounds closed or covered with a graft; culture results; host factors; environmental factors post-hospital discharge; and, financial charges related to admission and readmission. We expect full enrollment to take 3 years in duration. Debridement of the wound will be performed in the customary manner per SOC in the operating room. Prior to the start of the study, the surgeons performing the operations will be required to view a video that demonstrates the standardized debridement technique that will be utilized. The following is the standardized technique depicted in the video: All wound surfaces will be painted with dye prior to debridement. Debridement involves the use of a scalpel, scissors, curette, rongeur, or hydro-surgery. A 2-3 millimeter skin edge around the perimeter of the wound will also be resected. All infected/nonviable tissue will be removed and all tissues with dye will be surgically removed. This includes decompression of any purulent material and excision of any indurated tissue (until tissue pliability is established). Nonviable tissue includes necrotic and fibrous tissue. Debridement will be performed until the there is bleeding on the wound base and perimeter.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Wound Infection

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    Care Provider
    Allocation
    Randomized
    Enrollment
    250 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    2 operations
    Arm Type
    Active Comparator
    Arm Description
    Subjects in this arm will receive a maximum of two surgical debridements of their wound.
    Arm Title
    3 or more operations
    Arm Type
    Active Comparator
    Arm Description
    Subjects in this arm will receive three or more surgical debridements of their wound.
    Intervention Type
    Procedure
    Intervention Name(s)
    Debridement
    Intervention Description
    Removing dead tissue from infected wounds.
    Primary Outcome Measure Information:
    Title
    Number of post-hospital discharge complications between subjects who received 2 versus 3 or more debridement operations prior to closure.
    Time Frame
    180 Days

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    90 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Infected wound requiring hospital admission Infected wound requiring an operative intervention Wound can be located anywhere on the body Patient able and willing to comply with all study requirements Exclusion Criteria: Planned free tissue flap for soft tissue reconstruction Wound located over exposed joint implant Wound located over exposed hardware Disease or treatment causing substantial immunosuppression History of collagen vascular disease Transplant recipient Venous stasis ulcer Radiation-induced ulcer Contraindication for use of negative pressure wound therapy with instillation of normal saline Unable or unwilling to comply with study requirements
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Christopher Attinger, MD
    Organizational Affiliation
    MedStar Georgetown University Hospital
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    No
    IPD Sharing Plan Description
    Data was not collected for use in future research and will not be shared.

    Learn more about this trial

    Outcomes for 2 Operations Versus ≥ 3 Operations in Infected Wounds

    We'll reach out to this number within 24 hrs